Abstract
The process of therapeutic "electroporation" involves application of electric fields to target tumour cells, thereby rendering them transiently porous such that uptake of any deliberately introduced therapeutic agent present will be enhanced. The objective of this research programme is the development of flexible electrode arrays for incorporation into microsystem devices, and assessment of their efficacy in delivering selected genetic and pharmaceutical anti-cancer therapies. Gold electrodes were fabricated on flexible polyimide substrates following predictive modelling and simulation of electric fields using FEMLAB™ software. Subsequent assessment of electroporation efficiency involved enumeration of viable tumour cells and, where appropriate, quantification of emitted fluorescence by genetically altered cells.
| Original language | English |
|---|---|
| Pages (from-to) | 219-224 |
| Number of pages | 6 |
| Journal | Sensors and Actuators B: Chemical |
| Volume | 103 |
| Issue number | 1-2 |
| DOIs | |
| Publication status | Published - 29 Sep 2004 |
Keywords
- Cancer treatment
- Electroporation
- Gene therapy
- Microelectrodes